Stelara (ustekinumab) - J&J
Entyvio (vedolizumab) - Takeda
Induction of mucosal healing by biologics is topographically comparable in proximal and distal small bowel Crohn's disease. (PubMed, Clin Gastroenterol Hepatol) - Oct 6, 2026 - "Biologic therapy is associated with topographically comparable improvement in mucosal inflammation across proximal and distal SB segments." 
Journal • Crohn's disease • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • Mucositis
http://www.ncbi.nlm.nih.gov/pubmed/42833429
 
; Adam Goldman; Adi Talan Asher; Ahmad Albshesh; Bella Ungar; Doron Yablecovitch; Eyal Shachar; Offir Ukashi; Rami Eliakim; Shomron Ben-Horin; Tal Engel; Uri Kopylov
 
Oct 6, 2026
 
Prev Next